Streptococcal toxins

Area of Science:

• Microbiology and Immunology
• Toxicology
• Pathogenesis of Infectious Diseases

Background:

• Group A streptococci possess various cellular components and exotoxins with diverse biological activities.
• Understanding these components is crucial for elucidating the pathogenesis of streptococcal infections and associated diseases.

Purpose of the Study:

• To review and summarize the known toxic effects of group A streptococcal cellular components and exotoxins.
• To explore the potential mechanisms underlying scarlet fever and rheumatic fever pathogenesis related to these toxins.

Main Methods:

• Review of existing literature on group A streptococcal toxins and their effects.
• Analysis of experimental data from animal models and in vitro studies.
• Correlation of toxin properties with clinical manifestations like scarlet fever and rheumatic fever.

Main Results:

• M protein can induce immunotoxic effects on human platelets and neutrophils.
• Cell wall fragments cause chronic inflammatory lesions; peptidoglycans exhibit endotoxin-like properties.
• Erythrogenic toxins (pyrogenic exotoxins) may enhance hypersensitivity, contributing to scarlet fever symptoms.
• Streptolysin S lyses mammalian cells and affects lymphocyte functions, potentially causing leukotoxicity.
• Streptolysin O, a cytolysin, affects leukocyte function, cardiac cells, and exhibits ECG changes; its effect may be inhibited by epidermal cholesterol in skin infections.

Conclusions:

• Group A streptococcal toxins play multifaceted roles in disease pathogenesis, extending beyond direct cellular damage.
• Pyrogenic exotoxins and streptolysins are key mediators of streptococcal virulence and associated clinical syndromes.
• Further research into toxin-host interactions is needed to fully understand and combat streptococcal diseases.